European Study on Intravenous Immunoglobulin in Multiple Sclerosis
Arch Neurol 61:1409-1412, Filippi,M.,et al, 2004
Multiple Myeloma Invasion of the Central Nervous System
Arch Neurol 61:1423-1429, Schluterman,K.O.,et al, 2004
The Prevalence of Pain in Multiple Sclerosis, A Multicenter Cross-Sectional Study
Neurol 63:919-921, Solaro,C.,et al, 2004
Interferon Beta-1a for Brain Tissue Loss in Patients at Presentation with Syndromes Suggestive of Multiple Sclerosis: A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 364:1489-1496,1463, Filippi,M.,et al, 2004
An Unusual Cause of Visual Loss: Involvement of Bilateral Geniculate Bodies
AJNR 25:1544-1548, Lefebvre,P.R.,et al, 2004
PROTECT A Coordinated Stroke Treatment Program to Prevent Recurrent Thromboembolic Events
Neurol 63:1217-1222, Ovbiagele,B.,et al, 2004
Multiple Acute Cerebral Infarcts on Diffusion-Weighted Imaging and Risk of Recurrent Stroke
Neurol 63:1317-1319, Wen,H.M.,et al, 2004
Relapsing-Remitting Multiple Sclerosis and Human Herpesvirus 6 Active Infection
Arch Neurol 61:1523-1527, Alvarez-Lafuente,R.,et al, 2004
Long-Term Brain Magnetic Resonance Imaging Changes After Optic Neuritis in Patients Without Clinically Definite Multiple Sclerosis
Arch Neurol 61:1538-1541, Optic Neuritis Study Group, 2004
Intravenous Immunoglobulin Treatment Following the First Demyelinating Event Suggestive of Multiple Sclerosis
Archn Neurol 61:1515-1520, Achiron,A.,et al, 2004
Intravenous Immunoglobulin in Secondary Progressive Multiple Sclerosis: Randomised Placebo-Controlled Trial
Lancet 364:1149-1156, Hommes,O.R.,et al, 2004
The Bioavailability of IV Methylprednisolone and Oral Prednisone in Multiple Sclerosis
Neurol 63:1079-1080, Morrow,S.A.,et al, 2004
Donepezil Improved Memory in Multiple Sclerosis in a Randomized Clinical Trial
Neurol 63:1579-1585, Krupp,L.B.,et al, 2004
White Matter Lesions, Congition, and Recurrent Hemorrhage in Lobar Intracerebral Hemorrhage
Neurol 63:1606-1612, Smith,E.E.,et al, 2004
Treatment of Trigeminal Neuralgia Associated with Multiple Sclerosis
Neurol 63:1714-1715, Rasche,D.,et al, 2004
The Neurological and Cognitive Sequelae of Cardiac Arrest
Neurol 63:1774-1778, Lim,C.,et al, 2004
Interferon beta-1b in Secondary Progressive MS
Neurol 63:1779-1787,1768, Kappos,L.,et al, 2004
Interferon beta-1b in Secondary Progressive MS
Neurol 63:1788-1795,1768, The North American Study Group on Interferon beta-, 2004
Bilateral Carotid Artery Dissection With Thyrotoxicosis
Neurol 63:2443-2444, Campos,C.R.,et al, 2004
Clinical Characteristics of African Americans vs Caucasian Americans with Multiple Sclerosis
Neurol 63:2039-2045, Bree,B.A.C.,et al, 2004
IV Immunoglobulins as Add-on Treatment to Methylprednisolone for Acute Relapses in MS
Neurol 63:2028-2033, Sorensen,P.S.,et al, 2004
A Serum Autoantibody Marker of Neuromyelitis Optica: Distinction from Multiple Sclerosis
Lancet 364:2106-2112, Lennon,V.A.,et al, 2004
A Longitudinal Study of Brain Volume Changes in Normal Aging Using Serial Registered Magnetic Resonance Imaging
Arch Neurol 60:989-994, Scahill,R.I.,et al, 2003
A 48-Year-Old Man With Temporal Lobe Epilepsy and Psychiatric Illness
JAMA 290:381-392, Devinsky,O., 2003
High- and Low-Risk Profiles for the Development of Multiple Sclerosis Within 10 Years After Optic Neuritis
Arch Ophthalmol 121:944-949, Optic Neuritis Study Group, 2003
Frequency and Mechanisms of Stroke Recurrence After Cryptogenic Stroke
Ann Neurol 54:227-234, Bang,O.Y.,et al, 2003
Prolonged Treatment for Acute Symptomatic Refractory Status Epilepticus
Neurol 61:398-401, Sahin,M.,et al, 2003
Pain in Patients with Multiple Sclerosis
Arch Neurol 60:1089-1094, Svendsen,K.B.,et al, 2003
MR Features of Diseases Involving Bilateral Middle Cerebellar Peduncles
AJNR 24:1946-1954, Okamoto,K.,et al, 2003
Dirty-Appearing White Matter in Multiple Sclerosis: Volumetric MR Imaging and Magnetization Transfer Ratio Histogram Analysis
AJNR 24:1935-1940,1929, Ge,Y.,et al, 2003
Multifocal Varicella-Zoster Virus Vasculopathy Without Rash
Arch Neurol 60:1607-1609, Russman,A.N.,et al, 2003
Vasculitis of the Spinal Cord
Arch Neurol 60:1791-1794, Ropper,A.H.,et al, 2003
Recurrent Thromboembolism in Infants and Children Suffering from Symptomatic Neonatal Arterial Stroke
Stroke 34:2887-2893, Kurnik,K.,et al, 2003
A Corticosteroid-Reponsive Aneurysmal Lenticulostriate Vasculopathy
Neurol 61:1624-1625, Heran,N.S.,et al, 2003
The Use of Mitoxantrone (Novantrone) for the Treatment of Multiple Sclerosis
Neurol 61:1332-1338, Goodin,D.S.,et al, 2003
Hereditary Neuropathy With Liability to Pressure Palsies Mimicking Hypoglossal Nerve Injuries
Neurol 61:1457-1458, Corwin,H.M. &Girardet,R.E., 2003
Lupus and Zoster
Lancet 362:616, Douglas,K.M.J., 2003
Peripheral Third Cranial Nerve Enhancement in Multiple Sclerosis
AJNR 24:1390-1395, Bhatti,M.T.,et al, 2003
The Utility of MRI in Suspected MS, Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 61:602-611,596, Frohman,E.M.,et al, 2003
Seizure Remission and Antiepileptic Drug Discontinuation in Children with Tuberous Sclerosis Complex
Arch Neurol 60:1286-1289, Sparagana,S.P.,et al, 2003
Self Reported Stressful Life Events and Exacerbations in Multiple Sclerosis:Prospective Study
BMJ 327:646-649, Beljevac,D.,et al, 2003
A Wallerian Degeneration Pattern in Patients at Risk for MS
Neurol 54:1155-1160, Simion,J.H.,et al, 2003
Spinal Cord MRI in Clinically Isolated Optic Neuritis
JNNP 74:1577-1580, Dalton,C.M.,et al, 2003
Relationship Between Blood Pressure and Stroke Risk in Patients with Symptomatic Carotid Occlusive Disease
Stroke 34:2583-2592, Rothwell,P.M.,et al, 2003
Randomized, Concentration-Controlled Trial of Topiramate in Refractory Focal Epilepsy
Neurol 61:1210-1218, Christensen,J.,et al, 2003
Multiple Sclerosis Presenting as Lower Motor Neuron Wasting and Weakness of the Distal Upper Extremity
Neurol 61:1303-1304, Chong,P.S.T.,et al, 2003
Smoking is a Risk Factor for Multiple Sclerosis
Neurol 61:1122-1124, Riise,T.,et al, 2003
Hypoglossal Neuropathy in Hereditary Neuropathy with Liability to Pressure Palsy
Neurol 61:1154-1155, Winter,W.C. &Juel,V.C., 2003
Clinical Importance of Neutralising Antibodies Against Interferon Beta in Patients with Relapsing-Remitting Multiple Sclerosis
Lancet 362:1184-1191, Sorensen,P.S.,et al, 2003
Objective Assessments of Longitudinal Outcome in Gilles de la Tourette's Syndrome
Neurol 61:936-940, Pappert,E.J.,et al, 2003